Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial

M. Cavallin; Patrick S. Kamath; Manuela Merli; Silvano Fasolato; Pierluigi Toniutto; Francesco Salerno; Mauro Bernardi; Roberto Giulio Romanelli; C. Colletta; Freddy Salinas; Antonio Di Giacomo; Lorenzo Ridola; Ezio Fornasiere; Paolo Caraceni; Filippo Morando; Salvatore Piano; Angelo Gatta; Paolo Angeli

doi:10.1002/hep.27709

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Terlipressin plus albumin is significantly more effective than midodrine and octreotide plus albumin in improving renal function in patients with HRS.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cavallin et al. (2015) studied this question.

synapsesocial.com/papers/69dad1a478a3e0e28868476d https://doi.org/10.1002/hep.27709

View Full Paper

Ask AI

Bookmark

Share

Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial

Ask about this paper

Abstract

Discussion

Cite This Study

Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading